Vascular endothelial growth factor B (VEGF-B) is up-regulated and exogenous VEGF-B is neuroprotective in a culture model of Parkinson's disease
<p>Abstract</p> <p>Parkinson's disease (PD) results from the degeneration of dopaminergic neurons in the substantia nigra and the consequent deficit of dopamine released in the striatum. Current oral dopamine replacement or surgical therapies do not address the underlying issu...
Main Authors: | Zhang Shiling, Falk Torsten, Sherman Scott J |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2009-12-01
|
Series: | Molecular Neurodegeneration |
Online Access: | http://www.molecularneurodegeneration.com/content/4/1/49 |
Similar Items
-
Vascular endothelial growth factor B (VEGF-B) is up-regulated and exogenous VEGF-B is neuroprotective in a culture model of Parkinson's disease
by: Falk, Torsten, et al.
Published: (2009) -
Insights into the Mechanisms Involved in Protective Effects of VEGF-B in Dopaminergic Neurons
by: Beatrice Caballero, et al.
Published: (2017-01-01) -
Association of vascular endothelial growth factor B (VEGFВ) gene polymorphisms with intracranial aneurysms
by: R. I. Sultanova, et al.
Published: (2019-01-01) -
The Yin and Yang of VEGF and PEDF: Multifaceted Neurotrophic Factors and Their Potential in the Treatment of Parkinson’s Disease
by: Scott J. Sherman, et al.
Published: (2010-08-01) -
Vascular endothelial growth factor (VEGF) and prostate pathology
by: Francisco Botelho, et al.
Published: (2010-08-01)